Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (8,097,030)	$ (4,957,239)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation	349,240	65,663
Stock-based compensation	935,093	228,395
Accretion of discount on short-term investments	(23,383)	(108,999)
Credit losses	51,643	5,257
Amortization of deferred offering costs	60,045	0
Amortization of right-of-use assets	526,600	124,057
Other non-cash charges	(91,984)	44,631
Changes in operating assets and liabilities:
Accounts receivable	(2,975,272)	(102,234)
Inventories	(1,204,740)	(816,055)
Prepaid expenses and other current assets	(615,940)	(363,375)
Other assets	(130,801)	(214,937)
Accounts payable and accrued expenses	(531,182)	990,973
Income taxes payable	(144,392)	176,235
Operating lease liabilities	140,536	(237,365)
Deferred revenue	25,666	3,505
Tenant improvement allowance	183,726	0
Net cash used in operating activities	(11,542,175)	(5,161,488)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of short-term investments	(1,225,410)	(5,482,757)
Maturities of short-term investments	500,000	4,450,000
Purchases of equipment	(1,928,036)	(179,173)
Net cash used in investing activities	(2,653,446)	(1,211,930)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from common stock offering	0	4,598,771
Deferred debt origination costs	(36,506)	0
Proceeds from sale of pre-funded warrants, net of offering costs	0	763,138
Net Proceeds from issuance of debt	4,000,000	0
Net cash provided by financing activities	3,963,494	5,361,909
Effect of foreign exchange rate changes on cash	100,186	(13,697)
Net (decrease) increase in cash and cash equivalents	(10,131,941)	(1,025,206)
Cash and cash equivalents, beginning of period	24,747,373	6,871,306
Cash and cash equivalents, end of period	14,615,432	5,846,100
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Unrealized gain from mark to market on short-term investments	$ 268	$ 2,809